UnitedHealth Group Incorporated (UNH)
Elevance Health: Much Cheaper Than UNH, Yet No Drama
The market often misinterprets price declines as value. For Elevance Health, I see a disconnect between market cap and long-term earnings potential. Health sector valuations have dropped sharply, but lower multiples reflect uncertainty, not necessarily increased risk for robust companies like ELV. Elevance Health stands out for its ability to manage industry uncertainties and is well-positioned for a valuation re-rating as confidence returns.
CVS Beats Out UnitedHealth for Calpers Pharmacy Benefits Deal
CVS Health's Caremark business signed a new pharmacy benefits contract with the California Public Employees' Retirement System, known as Calpers.
UnitedHealth Group's Huge Day
Headwinds galore from regulatory scrutiny, Medicare Advantage costs, and management changes, but insiders are buying, and the valuation is historically cheap. Q2 earnings are likely to be the trough. Clarity on regulatory scrutiny and the potential for renewed share buybacks or guidance could be catalysts for the stock post-earnings.
UnitedHealth Group (UNH) Stock Slides as Market Rises: Facts to Know Before You Trade
In the latest trading session, UnitedHealth Group (UNH) closed at $300.58, marking a -1.16% move from the previous day.
UnitedHealth's Commercial Unit: A Stabilizer Amid Healthcare Turmoil?
UNH relies on its growing commercial insurance business as pressures from Medicare mount and industry headwinds persist.
Eyes On Elevance Health, Not UnitedHealth, As First To Report Earnings
For years now, UnitedHealth Group has been the first of the major health insurers to report its quarterly earnings. And Wall Street analysts and investors have looked to the healthcare giant -- which owns the nation's largest health insurer – for clues on how the sector is doing.
UnitedHealth: Down 50%, Is the Dividend Still Safe?
UnitedHealth Group (UNH 1.42%) faces a series of unprecedented challenges, from leadership crises to federal investigations, leading to a significant stock decline. Is this the end of its dominance?
UnitedHealth vs. Cigna: Which Insurer to Buy Amid Sector Turmoil?
CI's commercial focus and clearer outlook set it apart as UNH faces guidance pulls, CEO change and rising medical costs.
Is UnitedHealth (UNH) a Buy as Wall Street Analysts Look Optimistic?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
UnitedHealth Group Incorporated (UNH) is Attracting Investor Attention: Here is What You Should Know
UnitedHealth (UNH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
DOJ questions ex-UnitedHealth doctors in probe into Medicare fraud: report
The investigation, which dates back to at least last summer, concerns alleged efforts to encourage staffers to record certain diagnoses that trigger higher payments under Medicare Advantage, according to a report.
Do They Know Something? Insiders & Congress Buy UnitedHealth
Let's get the bad news out of the way first. The Eden Prairie, Minn.
